Skip to main content
. 2023 Jan 13;15(1):219. doi: 10.3390/v15010219

Table 1.

Immunized with recombinant adenovirus-based vaccine.

Immunogen Immunization Mode Immunization Dose
rAd-gD2ΔUL25 i.m. 1 × 108 PFU
rAd-gD2 + rAd-ΔUL25 i.m. 1 × 108 PFU + 1 × 108 PFU
rAd-gD2 i.m. 1 × 108 PFU
FI-HSV-2 i.m. 12.5 μg
Acyclovir p.o. 15 mg/kg
PBS i.m. 100 μL